BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7931812)

  • 1. Comparison of two Cobas Core enzyme immunoassays with other test systems for the detection of cytomegalovirus-specific IgG and IgM antibodies.
    Steinmann J; Weigel T
    J Clin Lab Anal; 1994; 8(4):191-9. PubMed ID: 7931812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women.
    Daiminger A; Bäder U; Eggers M; Lazzarotto T; Enders G
    J Clin Virol; 1999 Aug; 13(3):161-71. PubMed ID: 10443792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection.
    Chiereghin A; Pavia C; Gabrielli L; Piccirilli G; Squarzoni D; Turello G; Gibertoni D; Simonazzi G; Capretti MG; Lanari M; Lazzarotto T
    J Virol Methods; 2017 Oct; 248():250-254. PubMed ID: 28801056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard.
    Genser B; Truschnig-Wilders M; Stünzner D; Landini MP; Halwachs-Baumann G
    Clin Chem Lab Med; 2001 Jan; 39(1):62-70. PubMed ID: 11256803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
    Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
    Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
    Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection.
    BaAlawi F; Robertson PW; Lahra M; Rawlinson WD
    Pathology; 2012 Jun; 44(4):381-3. PubMed ID: 22531352
    [No Abstract]   [Full Text] [Related]  

  • 8. Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection.
    Weber B; Berger A; Rabenau H
    J Virol Methods; 2001 Aug; 96(2):157-70. PubMed ID: 11445146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CMV antibody determination with two enzyme immunoassays in each case].
    Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
    Lagrou K; Bodeus M; Van Ranst M; Goubau P
    J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay.
    Binnicker MJ; Jespersen DJ; Harring JA
    Clin Vaccine Immunol; 2010 Nov; 17(11):1734-8. PubMed ID: 20861325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
    Weber B; Fall EM; Berger A; Doerr HW
    J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
    Maine GT; Stricker R; Schuler M; Spesard J; Brojanac S; Iriarte B; Herwig K; Gramins T; Combs B; Wise J; Simmons H; Gram T; Lonze J; Ruzicki D; Byrne B; Clifton JD; Chovan LE; Wachta D; Holas C; Wang D; Wilson T; Tomazic-Allen S; Clements MA; Wright GL; Lazzarotto T; Ripalti A; Landini MP
    J Clin Microbiol; 2000 Apr; 38(4):1476-81. PubMed ID: 10747129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
    Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
    Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
    Prince HE; Leber AL
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.
    Revello MG; Vauloup-Fellous C; Grangeot-Keros L; van Helden J; Dickstein Y; Lipkin I; Mühlbacher A; Lazzarotto T
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3331-9. PubMed ID: 22850741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Abbott ARCHITECT™ cytomegalovirus IgM/IgG, rubella IgM/IgG, and syphilis treponemal antibodies enzyme immunoassays in a mother and child health center population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):231-235. PubMed ID: 30738692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
    Busse C; Strubel A; Schnitzler P
    J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenemia, immunoblotting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant patients.
    Fischer L; Rautenberg P; Bienengräber H; Leimenstoll G
    Transpl Int; 1993; 6(4):201-5. PubMed ID: 8394090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.